M. A. Aldouri

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

George J. Kontoghiorghes, M. A. Aldouri, A. V. Hoffbrand et al. · BMJ · 1987 · 190 citations · Full text

Iron Metabolism, Pharmacotherapy, Oral Chelator 1,2-Dimethyl-3-hydroxypyrid-4-one +19

1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD

GeorgeJ. Kontoghiorghes, L Sheppard, M. A. Aldouri et al. · The Lancet · 1987 · 180 citations · Full text

Biochemistry, Iron Metabolism, Medicine +3

High Incidence of Cardiomyopathy in Beta-Thalassaemia Patients Receiving Regular Transfusion and Iron Chelation: Reversal by Intensified Chelation

M. A. Aldouri, B. Wonke, A. V. Hoffbrand et al. · Acta Haematologica · 1990 · 167 citations

Mild Abnormality, Heart Failure, Cardiac Anaesthesia +17

Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.

M. A. Aldouri, B. Wonke, A. V. Hoffbrand et al. · Journal of Clinical Pathology · 1987 · 92 citations · Full text

Iron Metabolism, Pathology, Biopsy Specimens +18

ADOPTIVE TRANSFER OF HYPERTHYROIDISM AND AUTOIMMUNE THYROIDITIS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOID LEUKAEMIA

M. A. Aldouri, R. Ruggier, Owen Epstein et al. · British Journal of Haematology · 1990 · 64 citations

Transplant Rejection, Transplantation, Autoimmune Disease +11